Small RNAs regulate gene expression in many eukaryotes including plants, animals and fungi. miRNAs are endogenous short RNAs that modulate gene expression by blocking translation and/or destabilizing target mRNAs[@R1],[@R2]. In animals miRNAs are transcribed as long precursors (pri-miRNAs), which are processed in the nucleus by the RNase III enzyme complex Drosha-Pasha/DGCR8 to form \~80 nt pre-miRNAs, or are derived directly from introns[@R3]. pre-miRNAs are exported from the nucleus and processed by the RNase III enzyme Dicer, and incorporated into an Argonaute-containing RNA-induced silencing complex (RISC). The first identified miRNAs, the products of the *C. elegans* genes *lin-4* and *let-7*, control cell fates during larval development[@R4]. When either *lin-4* or *let-7* is inactivated, specific epithelial cells fail to differentiate and undergo additional divisions. *lin-4* acts during early larval development, regulating *lin-14* and *lin-28* mRNAs[@R4],[@R5],[@R6],[@R7],[@R8]. *let-7* acts during late larval development, regulating *lin-41, hbl-1, daf-12* and *pha-4* mRNAs[@R9],[@R10],[@R11],[@R12]. As such, the time of appearance of these miRNAs must be tightly controlled. In *C. elegans* and other animals the expression of *let-7* is developmentally regulated, but the mechanisms underlying this regulation remain unknown[@R13]. Post-transcriptional regulation of specific miRNAs has recently been uncovered[@R14]. *let-7* biogenesis is blocked by Lin28 at either the Drosha[@R15],[@R16] or Dicer[@R17],[@R18] step in mammalian cell culture. Lin28 is a conserved RNA-binding protein, which in mammals controls stem cell lineages and inhibits *let-7* miRNA processing *in vitro*[@R15],[@R16],[@R17],[@R18],[@R19]. However, the mechanism and *in vivo* significance of this activity are unclear.

RESULTS {#S1}
=======

An *in vivo* assay of let-7 miRNA function reveals developmental regulation {#S2}
---------------------------------------------------------------------------

To study the mechanism of miRNA action *in vivo*, we established a quantitative miRNA reporter assay based on *let-7* in *C. elegans* ([Fig 1a,b](#F1){ref-type="fig"} and [Supplementary Methods](#SD1){ref-type="supplementary-material"}). We generated two transgenes comprising the promoter of *myo-2*, the coding sequences of either GFP or mCherry and the 3′UTR of either *lin-41* or *unc-54* (*myo-2::gfp::lin-41* and *myo-2::mcherry::unc-54*; hereafter referred to as the *let-7 sensor*; [Fig. 1a](#F1){ref-type="fig"}). The *myo-2* promoter confers expression exclusively in the pharyngeal muscle, the food pump of *C*. elegans[@R20], and *lin-41* is a genetically identified target of the *let-7* miRNA[@R9], whereas the *unc-54* 3′UTR is not known to be regulated by any miRNA. Transgenic animals carrying an intrachromosomal array of the *let-7 sensor* expressed both GFP and mCherry strongly throughout larval development ([Fig. 1c](#F1){ref-type="fig"}). As expected, a transgene expressing *let-7* (*myo-2::let-7*) silenced GFP, but not mCherry ([Fig. 1d](#F1){ref-type="fig"}). Surprisingly, this effect was developmentally regulated; inhibition of GFP is markedly stronger in adults than L1 larvae ([Fig. 1d](#F1){ref-type="fig"}). As the *let-7* transgene does not contain the *let-7* promoter, this regulation must occur post-transcriptionally. In addition to the qualitative analysis of fluorescent protein expression using microscopy we quantified the activity of the *let-7 sensor* using flow cytometry of whole animals. We used a COPAS Biosort instrument to quantify GFP and mCherry expression along the body axis of thousands of individual animals at different stages during development. *let-7 sensor* silencing was least efficient at the L1 larval stage, and reached maximal efficiency during L3 ([Supplementary Methods](#SD1){ref-type="supplementary-material"} and [Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). This correlates with the temporal expression pattern of *let-7*, which begins to accumulate during the L3 stage[@R21]. Since let-7 is being driven by a promoter active at all stages, but appears active only at later larval stages, these data may reflect a mechanism that post-transcriptionally regulates *let-7* during development.

LIN-28 regulates pre-let-7 processing {#S3}
-------------------------------------

Next we carried out forward genetic and RNAi screens to identify factors regulating *let-7* activity *in vivo*. Knockdown of *lin-28* by RNAi resulted in reduced GFP at L1 and L2 stages, in a manner dependent on the myo-2::*let-7* transgene ([Supplementary Fig. 2a,b](#SD1){ref-type="supplementary-material"} and data not shown). We confirmed these results using a *lin-28* loss-of-function mutant ([Fig. 1e](#F1){ref-type="fig"} and data not shown). Mutations in *lin-46* completely suppress the developmental timing defect of *lin-28* mutants[@R22], but do not restore developmental regulation of *let-7* ([Fig. 1e](#F1){ref-type="fig"}). Thus deregulation of *let-7* activity in *lin-28* mutants is not an indirect consequence of developmental timing defects. Other heterochronic genes, including *lin-14* and *lin-42* did not affect the *let-7 sensor* ([Supplementary Fig. 2c](#SD1){ref-type="supplementary-material"} and data not shown). Next we tested if LIN-28 was sufficient to inhibit *let-7* activity. Ectopic expression of LIN-28 in the pharynx from an extrachromosomal array resulted in inhibition of *let-7* in adults, which do not normally express LIN-28[@R8] ([Fig. 1f](#F1){ref-type="fig"}). Mosaic expression of the extrachromosomal array within the pharynx indicated that LIN-28 acts cell autonomously. We concluded that LIN-28 is required and sufficient to inhibit *let-7* activity in *C. elegans*.

We then used miRNA microarrays and northern blotting to confirm that LIN-28 regulates endogenous *let-7* accumulation in L2 larvae ([Supplementary Data 1](#SD2){ref-type="supplementary-material"}; [Supplementary Fig. 3](#SD1){ref-type="supplementary-material"})[@R23]. Further, expression of other *let-7* family members was not increased in *lin-28* mutants, whereas three unrelated miRNAs, including the developmentally regulated miRNA miR-85, showed increased expression in *lin-28* mutant L2s ([Supplementary Fig. 3a,b](#SD1){ref-type="supplementary-material"}).

Whether Lin28 regulates *let-7* processing at the Drosha[@R15],[@R16] or Dicer[@R17],[@R18] step in mammalian cells is unresolved. We addressed this *in vivo* in *C. elegans*. We used northern blotting and qRT-PCR to compare expression of *let-7* and its processing intermediates from the *myo-2::let-7* transgene in otherwise wild-type and *lin-28* mutant L2 larvae. *lin-28* mutants expressed higher levels of *let-7* compared to wild type, indicating increased processing efficiency; this was accompanied by a slight reduction in the level of pre-*let-7*, and no change in pri-*let-7* levels; these data are consistent with increased efficiency of Dicer-mediated processing ([Supplementary Fig. 3c,d](#SD1){ref-type="supplementary-material"}). We obtained similar results for endogenous *let-7*, although levels of pri-*let-7* were decreased in *lin-28* mutants, suggesting an indirect effect on the *let-7* promoter ([Supplementary Fig. 3e,f](#SD1){ref-type="supplementary-material"}). Interestingly, miR-85 also appears to be regulated at the Dicer step in a *lin-28*-dependent fashion ([Supplementary Fig. 3b,g](#SD1){ref-type="supplementary-material"}). Consistent with these findings a functional LIN-28-GFP translational fusion is localised in the cytoplasm[@R8] ([Supplementary Fig. 4a](#SD1){ref-type="supplementary-material"} and data not shown). Taken together, these data suggest that LIN-28 blocks Dicer-mediated processing of *let-7* and possibly other developmentally regulated miRNAs.

Next, we tested whether LIN-28 directly interacts with pre-*let-7*. We performed pull-down assays using streptavidin beads and biotinylated pre-let-7. LIN-28-GFP from transgenic worm extracts was retained on streptavidin beads if the synthetic pre-*let-7* RNA was biotinylated, but not using a non-biotinylated control ([Supplementary Fig. 4b](#SD1){ref-type="supplementary-material"}). We tested whether this interaction was direct by native gel mobility shift assay. pre-*let-7* and GST-LIN-28 interact with an estimated K~d~ of 2 *μ*M ([Supplementary Fig. 4c](#SD1){ref-type="supplementary-material"} and data not shown). We conclude that LIN-28 binds pre-*let-7* to prevent Dicer processing. Experiments in mammalian cells suggested that the loop of the pre-*let-7* hairpin is required for the interaction with Lin28[@R15],[@R24]. However, the pre-*let-7* loop is not conserved in *C. elegans*. We therefore tested a number of pre-*let-7* loop mutants *in vivo* using the *let-7 sensor*. We found that the pre-*let-7* loop is not required for the normal developmental regulation of *let-7* activity (see [Supplementary Methods](#SD1){ref-type="supplementary-material"} and [Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}).

PUP-2 regulates pre-*let-7* processing in a *lin-28* dependent fashion {#S4}
----------------------------------------------------------------------

Our results so far were consistent with a LIN-28 blockade of pre-*let-7* processing, but we were puzzled that pre-*let-7* accumulation in L2 larvae differed little in wild-type compared to *lin-28* mutant animals ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}). We reasoned that LIN-28 might target pre-*let-7* for degradation. Recent work by Kim and colleagues demonstrated that Lin28 promotes pre-*let-7* uridylation and subsequent degradation in mammalian cell lines, although the enzyme(s) involved are unknown[@R18]. We inspected published high-throughput sequencing data of *C. elegans* small RNA libraries[@R25],[@R26], and found frequent modification of the 3′ end of *let-7*\* with 1 or 2 untemplated uracil residues (*C. elegans let-7* resides on the 5′ arm of the hairpin; [Fig. 2a](#F2){ref-type="fig"}). These species are likely to arise from Dicer processing of partially uridylated intermediates, and indicate *in vivo* uridylation of *let-7*. Therefore we carried out an RNAi screen against 15 potential poly(U) polymerases ([Supplementary Table 1](#SD1){ref-type="supplementary-material"}) assaying *let-7* and pre-*let-7* abundance in *myo-2::let-7* transgenic L2 larvae. RNAi against *pup-2* resulted in increased pre-*let-7* levels ([Fig. 2b,c](#F2){ref-type="fig"}; *P* = 7.5 × 10^−5^), and a small but significant increase in mature *let-7* levels ([Fig. 2b,d](#F2){ref-type="fig"}; *P* = 0.029). This effect is specific to *pup-2*, no other poly(U) polymerases, including *cid-1*, a potential paralogue, had this effect[@R27] ([Fig. 2c,d](#F2){ref-type="fig"}). These data suggest that PUP-2 uridylation targets pre-*let-7* for degradation, and is required for maximally efficient blockade of *let-7* processing by LIN-28. We reasoned that LIN-28 might target uridylation of pre-*let-7* by PUP-2, leading to degradation of the uridylated pre-*let-7* and turnover of LIN-28/pre-*let-7* complexes, ensuring efficient LIN-28 function. We examined the effect of *pup-2* RNAi in situations were pre-*let-7* is released from LIN-28 bockade. The effect of *pup-2* RNAi on pre- and mature *let-7* levels is abolished at the L4 stage ([Fig. 2c,d](#F2){ref-type="fig"} *P* = 1 × 10^−5^ and *P* = 0.01 respectively). Further, L2 larvae exposed to both *pup-2* and *lin-28* RNAi show significantly reduced accumulation of pre-*let-7* ([Fig. 2c](#F2){ref-type="fig"} *P* = 0.0003). These effects are not due to reduced RNAi against *pup-2* ([Supplementary Fig. 6a](#SD1){ref-type="supplementary-material"}). In contrast, the effect of *lin-28* RNAi on mature *let-7* levels is not altered in *lin-28, pup-2* double RNAi L2 larvae ([Fig. 2d](#F2){ref-type="fig"} *P* = 0.2). From these data we concluded that PUP-2 post-transcriptionally regulates *let-7* in a LIN-28-dependent fashion.

PUP-2 contributes to LIN-28-dependent regulation of *let-7* during development {#S5}
------------------------------------------------------------------------------

Next we sought to determine if PUP-2 is required for regulation of *let-7* during development. Misregulation of *let-7* results in altered timing of larval development, defects in differentiation of a hypodermal stem cell lineage required for the formation of adult-specific lateral alae[@R4], and defects in vulval morphogenesis [@R21]. Lateral seam cells differentiate and fuse into a syncytium in wild-type adults, but this fusion is defective if *pup-2* or *lin-28* is knocked down, consistent with a role in regulating *let-7* ([Fig. 2e](#F2){ref-type="fig"}, [Supplementary Table 2](#SD1){ref-type="supplementary-material"}). *pup-2* RNAi in a *lin-28* null mutant background does not increase seam cell fusion defects suggesting this activity of *pup-2* is *lin-28* dependent ([Table 1](#T1){ref-type="table"}). Next we tested whether *pup-2* genetically interacts with *let-7*. *let-7*(*n2853*ts) animals show reduced *let-7* expression and temperature sensitive vulval bursting[@R21]. At 15°C, vulval bursting of *let-7*(*n2853*ts) animals was suppressed by *pup-2* RNAi, whereas *lin-28* RNAi suppressed vulval bursting at both 15°C and 20°C ([Table 1](#T1){ref-type="table"}). Weaker suppression of *let-7(n2853ts)* by *pup-2* compared to *lin-28* is consistent with a role for *pup-2* as a *lin-28* modifier. Taken together with the effect of *pup-2* on *let-7* processing, these data indicate *pup-2* ensures efficient activity of *lin-28* by targeting blockaded pre-*let-7* molecules for destruction. This might occur via LIN-28 dependent uridylyl-transferase activity of PUP-2 on pre-*let-7*; we sought to test this hypothesis *in vitro*.

PUP-2 uridylates pre-*let-7* in a LIN-28 dependent fashion *in vitro* {#S6}
---------------------------------------------------------------------

We expressed HA-FLAG tagged PUP-2 and SBP tagged LIN-28 in a HEK293T human embryonic kidney cell line. Immunoprecipitation of HA-FLAG-PUP2 using anti-FLAG antibodies specifically co-precipitated SBP-LIN-28 ([Fig. 3a](#F3){ref-type="fig"}). This interaction was in absence of *C. elegans* pre-*let*-7 and likely direct. Indeed, the addition of excess exogenous pre-*let*-7 to the cell extract did not enhance the interaction. We also confirmed this interaction in GST pull-down experiments. *In vitro* translated PUP-2 directly interacts with GST-LIN-28 ([Fig. 3b](#F3){ref-type="fig"}). PUP-2 was previously shown to polyuridylate an artificially tethered RNA in *Xenopus* oocytes, but was inactive without tethering[@R27]. Therefore, we tested if LIN-28 might be able to recruit PUP-2 to mediate pre-*let-7* uridylation ([Fig. 3c](#F3){ref-type="fig"}). We incubated anti-FLAG immunoprecipitates from cell extracts expressing HA-FLAG-PUP2 and/or SBP-LIN-28 with radiolabeled pre-*let-7* and radiolabelled UTP. We find that HA-FLAG-PUP2 uridylated pre-*let-7* only in the presence of SBP-LIN-28 ([Fig. 3c](#F3){ref-type="fig"}). We also confirmed LIN-28 dependent uridylation of pre-*let-7* by PUP-2 *in vitro* ([Supplementary Fig. 6b](#SD1){ref-type="supplementary-material"}). Finally, we attempted to identify *in vivo* uridylated pre-*let-7* directly by cloning, but we were unable to do so. We conclude that rapid degradation of uridylated pre-*let-7* prevents accumulation of these species *in vivo*, as has been postulated in human cell lines[@R18].

DISCUSSION {#S7}
==========

We have developed a quantitative assay of *let-7* miRNA function in *C. elegans*. This assay is highly sensitive and amenable to high-throughput experiments. We have isolated new mutants in known miRNA pathway components through mutagenesis screens using this assay; analysis of novel miRNA function defective mutants should provide insights into the miRNA mechanism. In addition, this assay could be modified to study post-transcriptional regulation or target specificity of other miRNAs.

Here we demonstrate that LIN-28 regulates *C. elegans* pre-*let-7* (see [Supplementary Fig. 7a](#SD1){ref-type="supplementary-material"} for a model). These results provide a molecular basis for the genetic link between *lin-28* and *let-7* in controlling developmental timing. In *C. elegans* this pathway determines the behaviour of epithelial stem cells. In mammals let-7 and Lin28 might regulate primordial germ cell differentiation and other stem cell lineages[@R28]. Therefore, the specific interaction of a structured RNA (pre-let-7) with a protein (Lin28) constitutes an ultraconserved switch regulating stem cell differentiation. The let-7/lin-28 switch might be as conserved as let-7 itself. For example, pre-let-7 processing is developmentally regulated in the sea urchin *Strongylocentrotus purpuratus*[@R13], which also expresses a Lin28 orthologue (data not shown).

Our finding that the terminal loop of pre-let-7 is dispensable for regulation by LIN-28 is at odds with two previous studies[@R15],[@R16], but is consistent with competition experiments carried out by Rybak *et al.*[@R17]. Our approach has been to assess *let-7* function *in vivo*, whereas previous work was based on *in vitro* interaction studies. All 22 nucleotides of mature *let-7* are conserved in bilateria, whereas for many other miRNAs only the "seed" sequence (nucleotides 2 to 8) appears to be under evolutionary constraint. In contrast, there is little sequence similarity in the terminal loops of *let-7* in different species. It is therefore tempting to speculate that nucleotides corresponding to mature *let-7* contribute to LIN-28 recognition. Similar RNA-protein interactions might impose evolutionary constraint on the sequences of other ultraconserved miRNAs.

Here we show that LIN-28 recruits the poly(U) polymerase PUP-2 to uridylate *C. elegans* pre-*let-7*. We speculate that mammalian PUP-2 orthologues might similarly regulate *let-7* in stem cells ([Supplementary Fig. 7b](#SD1){ref-type="supplementary-material"}). Indeed, the mouse Tut4/Zcchc11 uridylyl transferase regulates let-7 in embryonic stem cells[@R29]. let-7 is a candidate tumour suppressor[@R21],[@R30],[@R31],[@R32] and LIN28 is a potential proto-oncoprotein[@R28],[@R33]. Therefore TUT4/ZCCHC11 might be an important novel target for anti-cancer therapy. Our data suggest that miRNAs are regulated through pre-miRNA sequestration and uridylation-dependent pre-miRNA degradation. This situation appears to be analogous to two-step regulation of the activity of proteins through sequestration and targeted degradation, for example in the case of cadherin[@R34]. Uridylation-dependent degradation of RNA has been observed previously and U tails have been shown to recruit either 5′ to 3′ or 3′ to 5′ exonucleases[@R35],[@R36]. High-throughput sequencing suggests additional miRNAs and/or pre-miRNAs are subject to uridylation (data not shown), so regulation in this way may be widespread. Further uncovering the mechanisms underlying this pathway will be of great interest.

Supplementary Material {#SM}
======================

**Supplementary Information** This information is provided as a collated PDF file including Supplementary Tables and Figures, and a 2 separate XLS data files.
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Online Methods {#S9}
==============

Nematode culture and strains {#S10}
----------------------------

We grew *C. elegans* under standard conditions at 20 °C[@R37]. The food source used was *E. coli* strain HB101 (*Caenorhabditis* Genetics Center, University of Minnesota, Twin Cities, MN, USA). We used bleaching followed by starvation-induced L1 arrest to generate synchronized cultures. The wild-type strain was var. Bristol N2[@R38]. Additional strains used are listed in [Supplementary Table 3](#SD1){ref-type="supplementary-material"}.

DNA constructs and transgenics {#S11}
------------------------------

We generated DNA vectors using the Multisite Gateway Three-Fragment vector construction kit (Invitrogen; [Supplementary Data 2](#SD3){ref-type="supplementary-material"}). We performed site directed mutagenesis using PCR and mutagenic primers ([Supplementary Data 2](#SD3){ref-type="supplementary-material"}). All constructs were confirmed by sequencing. To generate transgenic animals, we performed germline transformations as described[@R39]. Injection mixes contained 2-10 ng μl^−1^ of vector, 5-10 ng μl^−1^ of marker, and Invitrogen 1 kb ladder to a final concentration of 100 ng μl^−1^ DNA (see [Supplementary Methods](#SD1){ref-type="supplementary-material"} for details). We integrated array transgenes via X-ray irradiation as described[@R40]. We generated single copy transgenes by transposase mediated integration (mosSCI) as described[@R41].

Microscopy {#S12}
----------

We carried out differential interference contrast (DIC) and fluorescence imaging using standard methods[@R42] and using an AxioImager A1 upright microscope (Zeiss, Jena, Germany). We captured images using an ORCA-ER digital camera (Hamamatsu, Hamamatsu, Japan) and processed images using OpenLabs 4.0 software (Improvision, Coventry, UK). For analysis of *let-7 sensor* transgene expression, we imaged all animals under identical conditions. We performed confocal microscopy using an Olympus FluoView FV1000 upright microscope using 63x objective magnification.

Analyses with the COPAS Biosort instrument {#S13}
------------------------------------------

We used a COPAS Biosort instrument (Union Biometrica, Holliston, MA, USA) to simultaneously measure length (time of flight), absorbance (extinction), and fluorescence. We optimized fluorophore detection for simultaneous detection of GFP and mCherry. We used a multiline solid state argon laser for excitation (488nm GFP and 561nm mCherry), and detected emission by appropriate PMTs after passing through band pass filters (510/23nm GFP and 615/45nm mCherry). We harvested animals from plates and washed in M9 buffer[@R37] prior to sorting. We determined length and absorbance for each larval stage using synchronised wild-type populations. We then generated gates to isolate animals of specific developmental stages from mixed populations ([Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}).

RNA interference assays {#S14}
-----------------------

We obtained RNAi clones from genome-wide RNAi libraries[@R43],[@R44],[@R45]. We generated additional RNAi constructs by subcloning of an appropriate genomic DNA fragment into pDEST-L4440[@R45],[@R46] ([Supplementary Data 2](#SD3){ref-type="supplementary-material"}). We confirmed all RNAi constructs by sequencing. For experiments using *let-7 sensor* and *myo-2::let-7* transgenes we performed RNAi by feeding as described using the *eri-1*(*mg366*) RNAi hypersensitive genetic background[@R47]. For COPAS Biosort analysis, we plated 10-50 L1 larvae on 90 mm RNAi plates, and analysed animals once the oldest progeny reached the L3 larval stage. For harvest and RNA extraction we plated \~3,000 L1 larvae per RNAi plate and grew animals to adulthood prior to bleaching. After synchronisation by starvation, we plated the progeny onto fresh RNAi plates and grew to the desired stage before harvesting. We performed RNAi by injection as described[@R48]. We analyzed phenotypes on progeny laid 24-48 hrs post-injection.

Phenotypic analysis of seam cell development {#S15}
--------------------------------------------

We performed RNAi by injection into strains carrying seam cell marker transgenes *wIs51* and *mjIs15*.

Vulval bursting assay {#S16}
---------------------

*let-7*(*n2853*ts) embryos were added to RNAi plates by bleaching gravid adults, and grown at 15 °C. Non-burst adults were then transferred to fresh RNAi plates and temperature-shifted as required. L4 progeny were picked to fresh RNAi plates (15-25 animals per plate), and vulval bursting was scored after 48 hrs.

RNA Extraction {#S17}
--------------

For total RNA isolation we harvested animals from plates by washing with M9[@R37]. We pelleted and froze animals in liquid nitrogen and dissolved pellets in 10 volumes of Trizol reagent (Invitrogen, Carlsbad, CA, USA). We extracted total RNA was from Trizol reagent according to the manufacturer's protocol.

miRNA microrarray analysis {#S18}
--------------------------

We performed miRNA microarrays using custom DNA oligonucleotide arrays as described previously[@R49],[@R50]. Data analysis was as described[@R50]. To compare miRNA expression in wild-type and *lin-28* mutant L2 larvae we isolated and size selected total RNA from synchronized animals to 18-26 nt using polyacrylamide gel electrophoresis. The small RNA fraction was 3′ end-labelled using T4 RNA ligase (Fermentas UK, York, UK). *C. elegans* miRNA microarrays were based on miRbase release 8.0 [@R51],[@R52]. We performed all experiments in triplicates. For microarray probe information and primary microarray data see [Supplementary Data 1](#SD2){ref-type="supplementary-material"}.

Northern blotting {#S19}
-----------------

We performed northern blotting as described[@R25],[@R53], with the following modifications. We used 5-20 *μ*g total RNA, or small RNA fraction (miRvana, Ambion) isolated from \~200 *μ*g total RNA. For developmental expression profiles ([Supplementary Fig. 3a](#SD1){ref-type="supplementary-material"}) we carried out 1-ethyl-3-\[3-dimethylaminopropyl\]carbodimide hydrochloride (EDC, Perbio Science, Erembodegem, Belgium) crosslinking reactions for 2 hrs at 60 °C. Otherwise blots were UV-crosslinked. We modified northern hybridisations as follows; membranes were pre-hybridised at 40 °C for 4 hrs in hybridisation buffer (0.36 M Na~2~HPO~4~, 0.14 M NaH~2~PO~4~, 7% (v/v) SDS and 1 mg of sheared, denatured salmon sperm DNA) and hybridised at 40 °C overnight using 20 pmole of *γ*-^32^P-ATP-radiolabelled DNA oligonucleotide probes ([Supplementary Data 2](#SD3){ref-type="supplementary-material"}). After hybridisation, we washed membranes twice with 0.5 xSSC, 0.1 % (v/v) SDS at 40 °C for 10 min and once with 0.1 xSSC, 0.1 % (v/v) SDS at 40 °C for 5min. We detected radioactivity by phosphoimager (GE Healthcare, Amersham, UK). We quantified band intensity using ImageQuant software (GE Healthcare).

Real-time RT-PCR {#S20}
----------------

We performed RT-PCR as described[@R25], using the standard curve method. Primers used are listed in [Supplementary Data 2](#SD3){ref-type="supplementary-material"}.

pre-*let-7* pull-down {#S21}
---------------------

For these experiments we generated a strain carrying a rescuing *lin-28::gfp* translational fusion transgene (mosSCI integrated) in a *lin-28*(*n719*) mutant background. We prepared protein extracts from starvation synchronised L1 larvae. We cleared lysates against streptavadin Dynabeads (Invitrogen) for 30 min at 4 °C in PD buffer \[18 mM HEPES-KOH pH 7.9, 10 % (v/v) glycerol, 40 mM KCl, 2 mM MgCl~2~, 10 mM DTT, 100 *μ*M ZnSO~4~, 1x Proteinase Inhibitor Cocktail (PIC; Roche)\]. Dynabeads were blocked with 15 *μ*g yeast tRNA for 1 h at 4 °C in PD buffer before addition of 100 pmol synthetic 5′ biotinylated pre-*let-7* (Microsynth, Balgach, Switzerland) for pull-down, or unmodified synthetic pre-*let-7* for control reactions, and incubated for 1 hr at room temperature. We added pre-blocked Dynabeads to the binding reaction and incubated for 1 h at room temperature. We washed beads 3 times in PD buffer. We analyzed bound proteins by western blotting with primary mouse anti-GFP (Clontech JL-8; 1:1000) and secondary HRP-conjugated anti-mouse (Dakocytomation P0450; 1:10,000), or rat anti-tubulin (Chemicon international MAB1684, 1:1000) and secondary HRP-conjugated mouse anti-rat (GE Healthcare NA9310; 1:10,000).

Recombinant protein expression {#S22}
------------------------------

We obtained LIN-28 cDNA (F02E9.2b) from the ORFeome library[@R45]. We subcloned cDNAs into pDEST-GEX-2TK (Gateway cassette inserted at SmaI site in pGEX-2TK), or pDEST-MAL. We expressed and purified recombinant proteins as described[@R25],[@R54].

GST-pull-down {#S23}
-------------

We used PUP-2 cDNA in pDEST14 (Invitrogen) to produce [@R35]S-methionine-radiolabelled protein by *in vitro* transcription-translation using a TNT T7 coupled reticulocyte lysate kit (Promega). We performed pull-downs were performed using GST-LIN-28 as described[@R54].

Pre-*let-7* transcription {#S24}
-------------------------

We performed *in vitro* transcription reactions in a volume of 20 *μ*l with 0.5 mM of each NTP, 40 mM Tris pH 7.9, 12 mM MgCl~2~, 2 mM spermidine, 20 mM DTT, 1 mM NaCl, 100 U T7 RNA polymerase (Roche, Basel, Switzerland), and 1U RNasin (Promega, Madison WI, USA). We incubated reactions for 1 hr at 37 °C, prior to phenol/chloroform extraction and ethanol precipitation. We transcribed radiolabeled RNA for electrophoretic mobility shift assays with *α*-^32^P-UTP to a specific activity of approximately 6,000 cpm/fmol.

Immunoprecipitation {#S25}
-------------------

We cloned LIN-28 cDNA into pcDNA5/FRT/TO_GATEWAY_TEV_SBP. We cloned PUP-2 cDNA into pDEST-3FLAG 3HA. We performed immunoprcipitation assays as described previously[@R18]. Briefly, we transfected HEK293T cells with pHA-FLAG-PUP-2 and/or pLIN-28-SBP. After 48h we collected cells in cold lysis buffer (500mM NaCl, 1mM EDTA, 10 mMTris (pH8.0), 1% (v/v) Triton X-100), sonicated for 4 min on ice and centrifugated for 10 min. We incubated 50 *μ*l of the supernatant was with 5 *μ*l of pre-washed anti-FLAG antibody, conjugated to agarose beads (Sigma) and incubated for 2 hr at 4°C. We washed agarose-beads twice with lysis buffer and twice with buffer D. For *in vitro* uridylation, we incubated agarose beads in a 30 *μ*l reaction containing 3.2 mM of MgCl~2~, 1 mM of DTT and 0.25 mM of rUTP and 5′-end-labeled pre-miRNA of 1 × 10^4^-1 × 10^5^ cpm, for 20 min at 37 °C. We purified RNA by Trizol extraction and isopropanol precipitation. We analyzed reactions in a 12% urea polyacrylamide gel.

*In vitro* uridylation assays {#S26}
-----------------------------

We performed *in vitro* uridylation assays in 30 *μ*l reactions containing 1.5 *μ*g of *in vitro* transcribed pre-*let-7* in 10 mM Tris pH 7.5, 30 mM KCl, 1 mM DTT, 10 mM MnCl~2~, 2 mM MgCl~2~, 0.25 mM UTP, 1 *μ*l of RNaseOut and 0.01 Mbq *α*-^32^P-UTP. We added 1 *μ*g of recombinant MBP-PUP-2 and increasing amounts of recombinant GST-LIN-28 to a maximum of 10 *μ*g. We incubated reaction mixtures at 30 °C for 30 min. We purified RNA by phenol/chloroform extraction and ethanol precipitation. We analyzed reactions in a 6% urea polyacrylamide gel. We used 2U of *S. pombe* CID1 poly(U) polymerase (NEB, Ipswich, MA, USA) as a positive control. We detected radioactivity by phosphoimager (GE Healthcare).

Electrophoretic mobility shift assay {#S27}
------------------------------------

We carried out binding reactions in a total volume of 20 *μ*l containing 50,000 cpm of radiolabelled RNA, 30 *μ*g tRNA, 1 *μ*l RNaseOut (40 unit/*μ*l, Invitrogen), 50 mM Tris pH 7.6, 100 mM NaCl, 0.07 % (v/v) *β*-mercaptoethanol, 5 mM MgOAc~2,~ and increasing amounts of recombinant GST-LIN-28 to a maximum of 10 *μ*M. We incubated the reactions at room temperature for 45 min, followed by analysis using 5% native polyacrylamide gel electrophoresis. We detected radioactivity by phosphoimager (GE Healthcare).

![A quantitative assay reveals post-transcriptional regulation of the *let-7* miRNA by *lin-28*\
**(a,b)** Schematic of the pharynx based assay of *let-7* activity. **(c)** Fluorescence images of animals carrying the *let-7 sensor* transgene at L1 larval and adult stages. Both GFP and mCherry are strongly expressed.\
**d** Fluorescence images of animals carrying both the *let-7 sensor* and *myo-2::let-7* transgenes at L1 larval and adult stages. GFP is specifically and robustly downregulated in adults, but not in L1 larvae. Scale bar shows 20 μm.\
**e** Fluorescence images showing that *lin-28* mutants downregulate *let-7 sensor* GFP at the L1 stage in a *myo-2::let-7* dependent fashion. This effect is not reversed in a *lin-46* mutant background. Scale bar shows 20 μm.\
**f** Fluorescence images showing that a *myo-2::lin-28::unc-54* transgene is sufficient to block *let-7* activity in adults carrying *let-7 sensor* and *myo-2::let-7* transgenes. Scale bar shows 20 μm.](ukmss-31550-f0001){#F1}

![*pup-2* regulates *let-7* processing in a *lin-28*-dependent fashion\
**a** *let-7* is uridylated *in vivo*. Frequency of unmodified and modified *let-7*\* molecules identified by high-throughput sequencing.\
**b** Representative northern blot showing *pup-2*-dependent regulation of pre-*let-7*. 5 *μ*g of total RNA from control, *lin-28*(RNAi), and *pup-2*(RNAi) *myo-2::let-7* L2 larvae was loaded. U6 was used as a loading control.\
**c**,**d** Quantification of relative pre-*let-7* (**c**), and *let-7* (**d**) abundance in *lin-28*(RNAi), *pup-2*(RNAi) and *cid-1*(RNAi) *myo-2::let-7* L2 and L4 larvae from northern blotting experiments. Mean fold change relative to empty vector control samples is shown. *P*-values from Students' *t*-tests indicated; *n* = 4. Error bars show standard error of the mean.\
**e** Fluorescence image showing the seam cell defect observed in *pup-2*(RNAi) adults. A DLG-1-mCherry fusion marks seam cell boundaries. Upper panel; wild-type with continuous seam. Lower panel; *pup-2*(RNAi) with incompletely fused seam. Arrows indicate sites of failed fusion. Scale bar shows 20 μm.](ukmss-31550-f0002){#F2}

![LIN-28 interacts with PUP-2 and promotes uridylation of pre-*let-7* by PUP-2\
**a** Co-Immunoprecipitation of PUP-2 and LIN-28 expressed in HEK293T cells.\
**b** GST pull-down assay demonstrating a direct interaction of GST-LIN-28 and PUP-2 *in vitro*.\
**c** *In vitro* uridylation assay showing that PUP-2 uridylates pre-*let-7* in a LIN-28 dependent fashion.](ukmss-31550-f0003){#F3}

###### 

Genetic interactions of *pup-2* and *lin-28* with *let-7* in vulval development

  genotype                                \% burst at 20°C (*n*)   \% burst at 15°C (*n*)
  --------------------------------------- ------------------------ ------------------------
  *let-7*(*n2853*)*;* empty vector RNAi   97 (119)                 47 (86)
  *let-7*(*n2853*)*; lin-28*(RNAi)        16 (115)                 0 (28)
  *let-7*(*n2853*)*; pup-2*(RNAi)         97 (120)                 28 (114)

RNAi by feeding.
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